Raymond James & Associates Omeros Corp Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 16, 2024
SELL
$1.08 - $3.63 $36,172 - $121,579
-33,493 Reduced 75.4%
10,925 $35,000
Q3 2023

Oct 24, 2023
SELL
$2.81 - $5.69 $843 - $1,707
-300 Reduced 0.67%
44,418 $129,000
Q2 2023

Jul 25, 2023
SELL
$4.45 - $7.57 $67,195 - $114,307
-15,100 Reduced 25.24%
44,718 $243,000
Q1 2023

Apr 14, 2023
SELL
$2.48 - $5.22 $123,504 - $259,956
-49,800 Reduced 45.43%
59,818 $278,000
Q4 2022

Feb 08, 2023
BUY
$1.75 - $3.96 $10,675 - $24,156
6,100 Added 5.89%
109,618 $247,000
Q3 2022

Oct 25, 2022
SELL
$3.09 - $7.46 $40,170 - $96,980
-13,000 Reduced 11.16%
103,518 $326,000
Q2 2022

Aug 12, 2022
BUY
$1.92 - $6.28 $2,496 - $8,164
1,300 Added 1.13%
116,518 $320,000
Q1 2022

May 11, 2022
SELL
$5.07 - $7.2 $114,582 - $162,720
-22,600 Reduced 16.4%
115,218 $692,000
Q4 2021

Feb 08, 2022
BUY
$5.67 - $8.54 $60,623 - $91,309
10,692 Added 8.41%
137,818 $886,000
Q3 2021

Nov 02, 2021
BUY
$13.4 - $16.3 $498,748 - $606,686
37,220 Added 41.4%
127,126 $1.75 Million
Q2 2021

Aug 11, 2021
BUY
$14.81 - $19.13 $119,961 - $154,953
8,100 Added 9.9%
89,906 $1.33 Million
Q1 2021

May 14, 2021
SELL
$14.52 - $23.53 $179,917 - $291,560
-12,391 Reduced 13.15%
81,806 $1.46 Million
Q4 2020

Feb 12, 2021
SELL
$10.14 - $15.19 $53,742 - $80,507
-5,300 Reduced 5.33%
94,197 $1.35 Million
Q3 2020

Nov 04, 2020
BUY
$9.57 - $21.32 $50,692 - $112,932
5,297 Added 5.62%
99,497 $1.01 Million
Q2 2020

Jul 28, 2020
SELL
$12.21 - $16.99 $130,647 - $181,792
-10,700 Reduced 10.2%
94,200 $1.39 Million
Q1 2020

Apr 21, 2020
SELL
$9.03 - $19.72 $204,981 - $447,644
-22,700 Reduced 17.79%
104,900 $1.4 Million
Q4 2019

Feb 12, 2020
BUY
$13.01 - $17.15 $724,657 - $955,254
55,700 Added 77.47%
127,600 $1.8 Million
Q3 2019

Nov 07, 2019
BUY
$14.55 - $20.56 $97,485 - $137,752
6,700 Added 10.28%
71,900 $1.17 Million
Q2 2019

Aug 06, 2019
BUY
$15.0 - $19.62 $76,500 - $100,062
5,100 Added 8.49%
65,200 $1.02 Million
Q1 2019

May 06, 2019
SELL
$11.65 - $17.72 $1,165 - $1,772
-100 Reduced 0.17%
60,100 $1.04 Million
Q4 2018

Feb 11, 2019
BUY
$10.72 - $16.73 $138,288 - $215,817
12,900 Added 27.27%
60,200 $671,000
Q3 2018

Nov 14, 2018
BUY
$17.73 - $26.69 $8,865 - $13,345
500 Added 1.07%
47,300 $1.16 Million
Q2 2018

Aug 14, 2018
BUY
$10.79 - $24.44 $38,844 - $87,984
3,600 Added 8.33%
46,800 $849,000
Q1 2018

May 14, 2018
BUY
$9.0 - $20.16 $57,240 - $128,217
6,360 Added 17.26%
43,200 $483,000
Q4 2017

Feb 14, 2018
SELL
$13.26 - $22.86 $10,051 - $17,327
-758 Reduced 2.02%
36,840 $716,000
Q3 2017

Nov 13, 2017
SELL
$19.76 - $24.9 $342,677 - $431,815
-17,342 Reduced 31.57%
37,598 $813,000
Q2 2017

Aug 14, 2017
BUY
N/A
54,940
54,940 $1.09 Million

Others Institutions Holding OMER

# of Institutions
120
Shares Held
25.6M
Call Options Held
228K
Put Options Held
630K
View Full List

About OMEROS CORP

OMER Quotes by TradingView
  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $647M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email